Which of the following drugs can be used safely in porphyria?
Which of the following drugs can be administered safely to a patient with renal disease?
Which antihistaminic drug can cause cardiac arrhythmia at high doses by blocking cardiac K+ channels?
What condition is Febuxostat used to treat?
All of the following can cause hemolytic anemia EXCEPT:
Amyl nitrate is used as an antidote in which poisoning?
Megaloblastic anemia may be caused by all of the following except:
Fetal hydantoin syndrome is seen if which of the following drugs is used during pregnancy?
Tranexamic acid is a specific antidote of which class of drugs?
What is the drug of choice for organophosphorous poisoning?
Explanation: ### Explanation **Concept Overview:** Porphyrias are metabolic disorders characterized by defects in heme biosynthesis, leading to the accumulation of porphyrins. In patients with acute porphyrias (like Acute Intermittent Porphyria), certain drugs act as **enzyme inducers** of the cytochrome P450 system. These drugs increase the demand for heme, which upregulates **ALA synthase** (the rate-limiting enzyme), triggering a life-threatening acute crisis. **1. Why Option A is Correct:** * **Midazolam:** Most benzodiazepines, particularly midazolam, are considered **safe** or "non-porphyrinogenic" as they do not significantly induce ALA synthase. * **Sodium Valproate:** While historically debated, current clinical guidelines (such as the NAPOS database) classify Valproate as a **safe** alternative compared to other potent enzyme-inducing anticonvulsants. **2. Why Other Options are Incorrect:** * **Phenobarbitone (Options B & C):** This is a potent inducer of CYP enzymes and ALA synthase. It is strictly **contraindicated** and is a classic "trigger" drug for porphyric attacks. * **Ketamine (Option D):** Ketamine is considered **unsafe** in porphyria as it can stimulate porphyrin production. * **Pethidine (Option B):** While some opioids are safe (like Morphine or Fentanyl), Pethidine is generally avoided as it is considered potentially porphyrinogenic in some classifications. **3. High-Yield Clinical Pearls for NEET-PG:** * **Safe Drugs (The "Safe" List):** Morphine, Fentanyl, Propofol, Midazolam, Succinylcholine, and Aspirin. * **Unsafe Drugs (The "Porphyria Triggers"):** Barbiturates (Phenobarbitone, Thiopentone), Sulfonamides, Griseofulvin, Phenytoin, Carbamazepine, and Oral Contraceptive Pills. * **Management:** The drug of choice for treating an acute attack of porphyria is **Hematin (Heme arginate)**, which provides negative feedback to inhibit ALA synthase.
Explanation: **Explanation:** The selection of drugs in renal disease depends on the route of elimination and the potential for nephrotoxicity. **Correct Option: D. Diazepam** Diazepam is primarily metabolized by the **liver** via the cytochrome P450 system into active metabolites (like desmethyldiazepam), which are then conjugated and excreted. Since its primary clearance is hepatic rather than renal, it does not require significant dose adjustment in renal failure and is not nephrotoxic. However, clinicians should remain cautious of increased CNS sensitivity in uremic patients. **Why Incorrect Options are Wrong:** * **A. Phenacetin:** This is a classic nephrotoxin. Chronic use is strongly associated with **Analgesic Nephropathy**, characterized by renal papillary necrosis and chronic interstitial nephritis. It is no longer used clinically due to this toxicity. * **B. Tetracycline:** Most tetracyclines (except Doxycycline and Minocycline) are anti-anabolic. They increase protein breakdown, leading to an increase in BUN (**Azotemia**), which can aggravate pre-existing renal failure. * **C. Aminoglycosides:** These drugs (e.g., Gentamicin, Amikacin) are notorious for causing **Acute Tubular Necrosis (ATN)**. They are excreted unchanged by the kidneys and require strict therapeutic drug monitoring or dose interval extension in renal impairment. **NEET-PG High-Yield Pearls:** * **Safe in Renal Failure (The "D" Rule):** **D**oxycycline, **D**igoxin (Digitoxin is safer, but Digoxin requires monitoring), **D**icloxacillin, and **D**iazepam. * **Antibiotic of choice in renal failure:** Doxycycline (excreted via feces). * **Neuromuscular blocker of choice:** Atracurium or Cisatracurium (undergo Hofmann elimination). * **ACE Inhibitors:** Generally contraindicated in bilateral renal artery stenosis as they can precipitate acute renal failure.
Explanation: **Explanation:** The correct answer is **Astemizole**. **Mechanism of Toxicity:** Astemizole and Terfenadine are second-generation H1 antihistamines that were largely withdrawn from the market due to their cardiotoxic profile. At high doses or when their metabolism is inhibited (e.g., by CYP3A4 inhibitors like Ketoconazole or Erythromycin), these drugs block the **delayed rectifier potassium channels (IKr)** in the heart. This action prolongs the cardiac action potential duration and the QT interval on an ECG, leading to a life-threatening polymorphic ventricular tachycardia known as **Torsades de Pointes**. **Analysis of Options:** * **Astemizole (Correct):** Known for its potent blockade of cardiac K+ channels, leading to QT prolongation. * **Levo-cetrizine:** A metabolite of Hydroxyzine; it does not significantly block cardiac K+ channels and is considered cardiosafe. * **Fexofenadine:** This is the active metabolite of Terfenadine. Unlike its parent drug, Fexofenadine does not block K+ channels and was specifically developed as a non-cardiotoxic alternative. * **Loratadine:** While it is a second-generation antihistamine, it does not cause significant QT prolongation at therapeutic or even moderately high doses. **High-Yield Clinical Pearls for NEET-PG:** * **The "Terrible Two":** Remember **Terfenadine** and **Astemizole** as the primary antihistamines associated with Torsades de Pointes. * **Drug Interactions:** Toxicity is often precipitated by **CYP3A4 inhibitors** (Macrolides, Azole antifungals, Grapefruit juice) which prevent the breakdown of these pro-arrhythmic parent drugs. * **Safe Alternatives:** Fexofenadine, Cetirizine, and Loratadine are the preferred non-sedating, cardiosafe antihistamines.
Explanation: **Explanation:** **Febuxostat** is a potent, non-purine selective inhibitor of **Xanthine Oxidase (XO)**. It works by blocking the enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid. By reducing the production of uric acid, it effectively manages **Hyperuricemia**, making it a primary treatment for chronic gout. **Analysis of Options:** * **B. Hyperuricemia (Correct):** Febuxostat is indicated for the chronic management of hyperuricemia in patients with gout. Unlike Allopurinol (a purine analog), Febuxostat is a non-purine inhibitor, making it safer for patients with mild-to-moderate renal impairment as it is primarily metabolized by the liver. * **A. Hyperkalemia:** This refers to elevated potassium levels. Treatment typically involves calcium gluconate (for cardiac membrane stabilization), insulin with dextrose, or potassium binders like Patiromer. * **C. Hypernatremia:** This refers to elevated sodium levels, usually managed with free water replacement or hypotonic fluids (e.g., 0.45% Saline). * **D. Hypercalcemia:** This refers to elevated calcium levels. Management involves aggressive hydration, loop diuretics (Furosemide), and bisphosphonates. **NEET-PG High-Yield Pearls:** 1. **Mechanism:** Non-competitive inhibition of both the oxidized and reduced forms of Xanthine Oxidase. 2. **Drug-Drug Interaction:** Like Allopurinol, Febuxostat is contraindicated with **Azathioprine** and **6-Mercaptopurine**, as XO is required to metabolize these drugs; co-administration leads to severe bone marrow toxicity. 3. **Clinical Note:** Febuxostat is often preferred over Allopurinol in patients with chronic kidney disease (CKD) but carries a "Black Box Warning" for increased risk of cardiovascular death in patients with pre-existing heart disease.
Explanation: The core concept tested here is **Drug-Induced Hemolytic Anemia (DIHA)**, which typically occurs via two mechanisms: immune-mediated destruction or oxidative stress in individuals with **G6PD deficiency**. **Why Propranolol is the correct answer:** Propranolol is a non-selective beta-blocker used for hypertension, arrhythmias, and prophylaxis of migraine [1]. It has no known mechanism for causing red blood cell lysis or oxidative stress. Therefore, it is not associated with hemolytic anemia. **Analysis of Incorrect Options:** * **Isoniazid (INH):** While primarily known for hepatotoxicity and peripheral neuropathy, INH can cause immune-mediated hemolytic anemia (Type II hypersensitivity) and is also a potential oxidative stressor in G6PD-deficient patients. * **Rifampicin:** This drug is a well-known cause of **immune-mediated hemolysis**. It often occurs with intermittent dosing schedules where antibodies (IgM/IgG) are formed against the drug-RBC complex, leading to complement activation. * **Co-trimoxazole:** This is a combination of Sulfamethoxazole and Trimethoprim. **Sulfonamides** are classic "oxidant drugs" that precipitate acute hemolysis in patients with **G6PD deficiency** because they deplete reduced glutathione, leading to the formation of Heinz bodies [2]. **High-Yield Clinical Pearls for NEET-PG:** * **G6PD Deficiency "Avoid List":** Remember the mnemonic **"AAA"** — **A**ntimalarials (Primaquine), **A**ntibiotics (Sulfonamides, Nitrofurantoin), and **A**ntipyretics (high-dose Aspirin), plus Dapsone and Fava beans. * **Direct Coombs Test:** This is the gold standard investigation for diagnosing immune-mediated drug-induced hemolytic anemia (e.g., Penicillins, Methyldopa, Rifampicin). * **Bite Cells & Heinz Bodies:** These are characteristic peripheral smear findings in oxidative hemolysis (G6PD deficiency).
Explanation: **Explanation:** **Cyanide poisoning** is the correct answer because Amyl nitrite (administered via inhalation) is a key component of the traditional **Cyanide Antidote Kit**. **Mechanism of Action:** Cyanide acts by inhibiting **Cytochrome oxidase a3**, which halts the electron transport chain and leads to cellular hypoxia. Amyl nitrite works by oxidizing the iron in hemoglobin from the ferrous ($Fe^{2+}$) state to the ferric ($Fe^{3+}$) state, forming **Methemoglobin**. Methemoglobin has a high affinity for cyanide, pulling it away from the cytochrome oxidase to form **Cyanmethemoglobin**. This restores mitochondrial respiration. Subsequently, Sodium thiosulfate is given to convert cyanmethemoglobin into non-toxic **Thiocyanate**, which is excreted in the urine. **Analysis of Incorrect Options:** * **Carbon dioxide (A):** Toxicity is managed by removal from the source and supportive care (oxygenation); there is no role for nitrites. * **Carbon monoxide (B):** The treatment of choice is **100% Hyperbaric Oxygen**. Nitrites are contraindicated here because they produce methemoglobinemia, which would further reduce the oxygen-carrying capacity of blood already compromised by carboxyhemoglobin. * **Nitric acid (D):** This is a corrosive acid; management involves stabilization and supportive care, not nitrites. **High-Yield Clinical Pearls for NEET-PG:** * **Hydroxocobalamin** is now the preferred first-line antidote for cyanide poisoning (it forms Cyanocobalamin/Vitamin B12). * **Classic sign:** "Cherry-red" skin discoloration and a "bitter almond" odor on the breath. * **Caution:** Avoid nitrites if concurrent Carbon Monoxide poisoning is suspected (e.g., fire victims).
Explanation: ### Explanation Megaloblastic anemia is primarily caused by a deficiency or impaired utilization of **Vitamin B12 (Cobalamin)** or **Folic Acid (Vitamin B9)**, both of which are essential for DNA synthesis [1]. **Why Amoxicillin is the Correct Answer:** Amoxicillin is a beta-lactam antibiotic that acts by inhibiting bacterial cell wall synthesis (binding to penicillin-binding proteins). It does not interfere with human folate metabolism, DNA synthesis, or Vitamin B12 absorption. Therefore, it does not cause megaloblastic anemia. **Why the Other Options are Incorrect:** * **Phenytoin:** This antiepileptic drug causes megaloblastic anemia by **inhibiting the enzyme intestinal conjugase**, which reduces the absorption of dietary folates. Long-term use often requires folic acid supplementation. * **Methotrexate:** This is a potent **dihydrofolate reductase (DHFR) inhibitor**. It prevents the conversion of dihydrofolate to tetrahydrofolate (the active form), directly halting DNA synthesis [3]. * **Pyrimethamine:** Similar to methotrexate, this antiparasitic drug (used in malaria and toxoplasmosis) inhibits DHFR [2]. While it has a higher affinity for protozoal enzymes, high doses can affect human folate metabolism. **NEET-PG High-Yield Clinical Pearls:** 1. **Other Drugs causing Megaloblastic Anemia:** Trimethoprim (DHFR inhibitor), 5-Fluorouracil (Thymidylate synthase inhibitor), Hydroxyurea, and Zidovudine (AZT). 2. **Nitrous Oxide:** Prolonged exposure can cause megaloblastic anemia by oxidizing the cobalt atom in Vitamin B12, inactivating methionine synthase. 3. **Rescue Therapy:** To prevent methotrexate toxicity, **Leucovorin (Folinic acid)** is administered, as it bypasses the inhibited DHFR enzyme [3]. 4. **Key Lab Finding:** Look for **hypersegmented neutrophils** on a peripheral blood smear as an early sign of megaloblastic changes.
Explanation: **Explanation:** **Phenytoin** is the correct answer. It is a widely used antiepileptic drug that acts by blocking voltage-gated sodium channels. When used during pregnancy, it is highly teratogenic, leading to a specific constellation of defects known as **Fetal Hydantoin Syndrome (FHS)**. The underlying mechanism involves the formation of epoxide metabolites that cause oxidative stress during fetal development. **Clinical Features of Fetal Hydantoin Syndrome:** * **Craniofacial:** Cleft lip/palate, broad nasal bridge, and hypertelorism. * **Skeletal:** Hypoplasia of the distal phalanges and nails (a very high-yield feature). * **Growth:** Microcephaly and intrauterine growth restriction (IUGR). **Analysis of Incorrect Options:** * **Alcohol:** Causes **Fetal Alcohol Syndrome (FAS)**, characterized by a smooth philtrum, thin upper lip, short palpebral fissures, and significant intellectual disability. * **Ethosuximide:** Primarily used for absence seizures; while all older AEDs carry some risk, it is not associated with Fetal Hydantoin Syndrome. * **Phenobarbitone:** Can cause cardiac defects and orofacial clefts, but the specific syndrome involving digital hypoplasia is unique to Phenytoin [1]. **High-Yield NEET-PG Pearls:** 1. **Drug of Choice (DOC) for Epilepsy in Pregnancy:** Levetiracetam or Lamotrigine (lower teratogenic potential). 2. **Valproate:** The most teratogenic AED, causing **Neural Tube Defects** (due to interference with folate metabolism) [1]. 3. **Prevention:** High-dose Folic acid (4-5 mg/day) is recommended for women on AEDs planning pregnancy to reduce the risk of malformations.
Explanation: **Explanation:** **1. Why Fibrinolytic drugs is correct:** Tranexamic acid (TXA) is a **synthetic derivative of the amino acid lysine**. It acts as a competitive inhibitor of plasminogen activation. Fibrinolytic drugs (like Streptokinase or Alteplase) work by converting plasminogen to plasmin, which degrades fibrin clots. TXA binds to the lysine-binding sites on plasminogen molecules, preventing them from binding to fibrin. This effectively blocks the action of plasmin and inhibits fibrinolysis. Therefore, it is the specific antidote used to manage bleeding complications induced by fibrinolytic overdose. **2. Why the other options are incorrect:** * **Heparin:** The specific antidote for heparin overdose is **Protamine sulfate**, which neutralizes heparin through a chemical (ionic) antagonism. * **Barbiturates:** There is no specific pharmacological antidote for barbiturates. Management is primarily supportive (alkalinization of urine for phenobarbital and gastric lavage). * **Organophosphates:** The specific antidotes are **Atropine** (to block muscarinic effects) and **Pralidoxime/2-PAM** (to reactivate acetylcholinesterase). **3. NEET-PG High-Yield Pearls:** * **Mechanism:** TXA is an **antifibrinolytic**. It does not promote clotting but prevents the breakdown of existing clots. * **Clinical Uses:** Beyond fibrinolytic reversal, it is high-yield for **Menorrhagia**, **Post-partum hemorrhage (PPH)**, and trauma-induced bleeding (CRASH-2 trial). * **Contraindication:** It should be avoided in patients with active intravascular clotting (e.g., DVT or PE) due to the risk of stabilizing pathological thrombi. * **Alternative:** **Epsilon-aminocaproic acid (EACA)** is another antifibrinolytic with a similar mechanism but is less potent than TXA.
Explanation: **Explanation:** **Organophosphorous (OP) poisoning** occurs due to the irreversible inhibition of the enzyme **Acetylcholinesterase (AChE)**. This leads to an accumulation of acetylcholine at muscarinic and nicotinic receptors, causing a "cholinergic crisis." **Why PAM is the Correct Answer:** **Pralidoxime (PAM)** belongs to a class of drugs known as **Cholinesterase Reactivators** [1], [2]. It works by binding to the anionic site of the phosphorylated enzyme, pulling the phosphate group away from the serine active site, thereby restoring enzyme activity [2], [3]. * **Crucial Note:** PAM must be administered early, before **"aging"** of the enzyme occurs (the chemical bond becomes permanent) [1], [3]. While Atropine is the drug of choice for symptomatic management (muscarinic symptoms), PAM is the specific antidote for reversing the underlying pathology, especially at the neuromuscular junction [1]. **Why Other Options are Incorrect:** * **A. EDTA (Ethylene Diamine Tetraacetic Acid):** This is a chelating agent used primarily for **Lead poisoning**. It has no role in OP poisoning. * **B. BAL (British Anti-Lewisite / Dimercaprol):** This is a chelating agent used for heavy metal poisoning such as **Arsenic, Mercury, and Gold**. It is contraindicated in OP poisoning. **High-Yield Clinical Pearls for NEET-PG:** 1. **Atropine vs. PAM:** Atropine is the "Physiological Antidote" (blocks muscarinic receptors); PAM is the "Specific Antidote" (reactivates the enzyme) [1]. 2. **Atropinization:** The goal of treatment is to achieve signs of atropinization (mydriasis, tachycardia, and clearing of lung secretions). 3. **Aging:** Once the enzyme-toxin complex "ages," oximes like PAM are no longer effective [3]. 4. **Contraindication:** Oximes are generally not recommended in **Carbamate poisoning** because the enzyme-carbamate bond is reversible and short-lived.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free